ResearcherActive in the last 2 years

Helena F. Florindo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4006-5840; OpenAlex author ID A5081793497. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis Last author DOI 10.21203/rs.3.rs-9958073/v1 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guy Lahat · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Daniella Vaskovich‐Koubi · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Lior Orbach · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Ronit Satchi‐Fainaro · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗
Dov Hershkovitz · 1 shared paper, 2026 · strength 0.24
- Paper Lymph node-targeted Nanovaccine Reshapes the Tumor Microenvironment to Suppress PDAC Progression and Metastasis DOI 10.21203/rs.3.rs-9958073/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.